MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial

R. Nimri; I. Muller; E. Atlas; S. Miller; A. Fogel; N. Bratina; O. Kordonouri; T. Battelino; T. Danne; M. Phillip

doi:10.1089/dia.2016.2509

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial

R. Nimri, I. Muller, E. Atlas, S. Miller, A. Fogel, N. Bratina, O. Kordonouri, T. Battelino, T. Danne, M. Phillip

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	S94-S95
Journal	Diabetes Technology and Therapeutics
Volume	18
DOIs	https://doi.org/10.1089/dia.2016.2509
State	Published - Feb 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/dia.2016.2509

Cite this

@article{69453fa2a3b7461d8d12faa7ce3010c3,

title = "MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial",

author = "R. Nimri and I. Muller and E. Atlas and S. Miller and A. Fogel and N. Bratina and O. Kordonouri and T. Battelino and T. Danne and M. Phillip",

year = "2016",

month = feb,

doi = "10.1089/dia.2016.2509",

language = "אנגלית",

volume = "18",

pages = "S94--S95",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes

T2 - Randomized crossover trial

AU - Nimri, R.

AU - Muller, I.

AU - Atlas, E.

AU - Miller, S.

AU - Fogel, A.

AU - Bratina, N.

AU - Kordonouri, O.

AU - Battelino, T.

AU - Danne, T.

AU - Phillip, M.

PY - 2016/2

Y1 - 2016/2

UR - http://www.scopus.com/inward/record.url?scp=84957639666&partnerID=8YFLogxK

U2 - 10.1089/dia.2016.2509

DO - 10.1089/dia.2016.2509

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 26836433

AN - SCOPUS:84957639666

SN - 1520-9156

VL - 18

SP - S94-S95

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

ER -

MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial

UN SDGs

Access to Document

Other files and links

Cite this